KEGG   PATHWAY: ko04640
Entry
ko04640                     Pathway                                
Name
Hematopoietic cell lineage
Description
Blood-cell development progresses from a hematopoietic stem cell (HSC), which can undergo either self-renewal or differentiation into a multilineage committed progenitor cell: a common lymphoid progenitor (CLP) or a common myeloid progenitor (CMP). A CLP gives rise to the lymphoid lineage of white blood cells or leukocytes-the natural killer (NK) cells and the T and B lymphocytes. A CMP gives rise to the myeloid lineage, which comprises the rest of the leukocytes, the erythrocytes (red blood cells), and the megakaryocytes that produce platelets important in blood clotting. Cells undergoing these differentiation process express a stage- and lineage-specific set of surface markers. Therefore cellular stages are identified by the specific expression patterns of these genes.
Class
Organismal Systems; Immune system
Pathway map
ko04640  Hematopoietic cell lineage
ko04640

Orthology
K00977  DNTT; DNA nucleotidylexotransferase [EC:2.7.7.31]
K01242  CD38; ADP-ribosyl cyclase 1 [EC:3.2.2.6 2.4.99.20]
K01389  MME, CD10; neprilysin [EC:3.4.24.11]
K03156  TNF, TNFA; tumor necrosis factor superfamily, member 2
K04006  DAF, CD55; decay accelerating factor
K04008  CD59; CD59 antigen
K04011  CR1, CD35; complement component (3b/4b) receptor 1
K04012  CR2, CD21; complement receptor type 2
K04383  IL1A; interleukin 1 alpha
K04386  IL1R1, CD121a; interleukin 1 receptor type I
K04387  IL1R2, CD121b; interleukin 1 receptor type II
K04391  CD14; monocyte differentiation antigen CD14
K04519  IL1B; interleukin 1 beta
K04736  IL3; interleukin 3
K04737  IL3RA, CD123; interleukin 3 receptor alpha
K05055  IL6R, CD126; interleukin 6 receptor
K05056  IL11RA; interleukin 11 receptor alpha
K05061  CSF3R, CD114; granulocyte colony-stimulating factor receptor
K05066  CSF2RA, GMCSFR, CD116; granulocyte-macrophage colony-stimulating factor receptor alpha
K05067  IL5RA, CD125; interleukin 5 receptor alpha
K05068  IL2RA, CD25; interleukin 2 receptor alpha
K05071  IL4R, CD124; interleukin 4 receptor
K05072  IL7R, CD127; interleukin 7 receptor
K05073  IL9R, CD129; interleukin 9 receptor
K05079  EPOR; erythropoietin receptor
K05090  CSF1R, FMS, CD115; macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]
K05091  KIT, SCFR, CD117; proto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]
K05092  FLT3, FLK2, CD135; fms-related tyrosine kinase 3 [EC:2.7.10.1]
K05405  IL6; interleukin 6
K05417  IL11; interleukin 11
K05423  CSF3, GCSF; granulocyte colony-stimulating factor
K05427  CSF2, GMCSF; granulocyte-macrophage colony-stimulating factor
K05428  IL5; interleukin 5
K05430  IL4; interleukin 4
K05431  IL7; interleukin 7
K05437  EPO; erythropoietin
K05453  CSF1, MCSF; macrophage colony-stimulating factor 1
K05454  FLT3LG; fms-related tyrosine kinase 3 ligand
K05461  KITLG; KIT ligand
K06256  CD44; CD44 antigen
K06259  CD36; CD36 antigen
K06260  GP5, CD42d; platelet glycoprotein V
K06261  GP1BA, CD42b; platelet glycoprotein Ib alpha chain
K06262  GP1BB, CD42c; platelet glycoprotein Ib beta chain
K06263  GP9, CD42a; platelet glycoprotein IX
K06448  CD1; T-cell surface glycoprotein CD1
K06449  CD2; T-cell surface glycoprotein CD2
K06450  CD3D; T-cell surface glycoprotein CD3 delta chain
K06451  CD3E; T-cell surface glycoprotein CD3 epsilon chain
K06452  CD3G; T-cell surface glycoprotein CD3 gamma chain
K06454  CD4; T-cell surface glycoprotein CD4
K06455  CD5; T-cell surface glycoprotein CD5
K06457  CD7; T-cell surface glycoprotein CD7
K06458  CD8A; T-cell surface glycoprotein CD8 alpha chain
K06459  CD8B; T-cell surface glycoprotein CD8 beta chain
K06460  CD9, TSPAN29; CD9 antigen
K06461  ITGAM, CD11b; integrin alpha M
K06465  CD19; B-lymphocyte antigen CD19
K06466  MS4A1, CD20; B-lymphocyte antigen CD20
K06467  CD22, SIGLEC2; CD22 antigen
K06468  FCER2, CD23; low affinity immunoglobulin epsilon Fc receptor
K06469  CD24; CD24 antigen
K06473  CD33, SIGLEC3; CD33 antigen
K06474  CD34; CD34 antigen
K06475  CD37, TSPAN26; CD37 antigen
K06476  ITGA2B, CD41; integrin alpha 2B
K06480  ITGA1, CD49a; integrin alpha 1
K06481  ITGA2, CD49b; integrin alpha 2
K06482  ITGA3, CD49c; integrin alpha 3
K06483  ITGA4, CD49d; integrin alpha 4
K06484  ITGA5, CD49e; integrin alpha 5
K06485  ITGA6, CD49f; integrin alpha 6
K06493  ITGB3, CD61; integrin beta 3
K06498  FCGR1A, CD64; high affinity immunoglobulin gamma Fc receptor I
K06503  TFRC, CD71; transferrin receptor
K06575  GYPA, CD235a; glycophorin A
K06752  MHC2; MHC class II antigen
K06854  THPO; thrombopoietin
K06856  IGH; immunoglobulin heavy chain
K11140  ANPEP, CD13; aminopeptidase N [EC:3.4.11.2]
Reference
  Authors
Janeway CA Jr, Travers P, Walport M, Shlomchik MJ
  Title
Immunobiology - International editon: The immune system in health and disease
  Journal
Harcourt Publishers Ltd, a subsidiary of Harcourt International Ltd (2001)
Reference
  Authors
Abe T
  Title
[Atlas of malignancies in hematopoietic organ - Morphology, immunology, chromosome and gene] (In Japanese)
  Journal
Nihonijishinhousya (2000)
Reference
  Authors
Rothenberg EV, Taghon T.
  Title
Molecular genetics of T cell development.
  Journal
Annu Rev Immunol 23:601-49 (2005)
DOI:10.1146/annurev.immunol.23.021704.115737
Reference
  Authors
Ceredig R, Rolink T.
  Title
A positive look at double-negative thymocytes.
  Journal
Nat Rev Immunol 2:888-97 (2002)
DOI:10.1038/nri937
Reference
  Authors
de Bruijn MF, Speck NA.
  Title
Core-binding factors in hematopoiesis and immune function.
  Journal
Oncogene 23:4238-48 (2004)
DOI:10.1038/sj.onc.1207763
Reference
  Authors
Radtke F, Wilson A, Mancini SJ, MacDonald HR.
  Title
Notch regulation of lymphocyte development and function.
  Journal
Nat Immunol 5:247-53 (2004)
DOI:10.1038/ni1045
Reference
  Authors
Spits H.
  Title
Development of alphabeta T cells in the human thymus.
  Journal
Nat Rev Immunol 2:760-72 (2002)
DOI:10.1038/nri913
Reference
PMID:9927518
  Authors
Di Santo JP, Aifantis I, Rosmaraki E, Garcia C, Feinberg J, Fehling HJ, Fischer A, von Boehmer H, Rocha B.
  Title
The common cytokine receptor gamma chain and the pre-T cell receptor provide independent but critically overlapping signals in early alpha/beta T cell development.
  Journal
J Exp Med 189:563-74 (1999)
DOI:10.1084/jem.189.3.563
Reference
  Authors
Mak TW, Penninger JM, Ohashi PS.
  Title
Knockout mice: a paradigm shift in modern immunology.
  Journal
Nat Rev Immunol 1:11-9 (2001)
DOI:10.1038/35095551
Reference
  Authors
Shapiro-Shelef M, Calame K.
  Title
Regulation of plasma-cell development.
  Journal
Nat Rev Immunol 5:230-42 (2005)
DOI:10.1038/nri1572
Reference
  Authors
Maillard I, Adler SH, Pear WS.
  Title
Notch and the immune system.
  Journal
Immunity 19:781-91 (2003)
DOI:10.1016/S1074-7613(03)00325-X
Reference
  Authors
Alpdogan O, van den Brink MR.
  Title
IL-7 and IL-15: therapeutic cytokines for immunodeficiency.
  Journal
Trends Immunol 26:56-64 (2005)
DOI:10.1016/j.it.2004.11.002

DBGET integrated database retrieval system